Molbio IPO allotment today after 70x subscription: Here's how to check status

Molbio IPO allotment today after 70x subscription: Here's how to check status

Molbio Diagnostics IPO received a strong response from investors, with the issue subscribed more than 70 times by the time bidding closed on August 12. The allotment of shares is expected to be finalised today, August 13, leaving investors waiting to find out whether they have received an allotment.The Rs 939.70 crore Molbio Diagnostics IPO was subscribed 70.27 times overall. The qualified institutional buyer (QIB) portion, excluding anchor investors, was subscribed 186.39 times, while the non-institutional investor (NII) portion was subscribed 49.80 times. The retail portion was subscribed 12.97 times.Investors can check their Molbio Diagnostics IPO allotment status through the IPO registrar Kfin Technologies, as well as the BSE and NSE websites.HOW TO CHECK ON KFINTECHKfin Technologies is the registrar for the Molbio Diagnostics IPO and is one of the main platforms investors can use to check their allotment status. Visit the Kfin Technologies IPO status page and select Molbio Diagnostics Limited from the dropdown menu.Investors can check their application using their PAN, application number, DP ID/Client ID or bank account number/IFSC. Enter the required details and submit the form to view the Molbio Diagnostics IPO allotment status.HOW TO CHECK ON BSE AND NSEInvestors can also check their Molbio Diagnostics IPO allotment status on the BSE website.Visit the BSE IPO application status page.Select Equity and choose Molbio Diagnostics Limited from the issue list. Enter the PAN or application number, complete the captcha and click on "Search".The allotment status will then be displayed.Investors can also check their IPO bid details through the NSE website.Visit the NSE IPO bid verification page and select Equity and SME IPO Bid Details.Choose Molbio Diagnostics Limited, enter the required details and submit the form to check the application information.CHECK THROUGH YOUR BROKERInvestors can also check their IPO application status through their trading platform or broker's app.After logging in, go to the IPO section or Order Book and look for Molbio Diagnostics IPO. The application status can show whether the shares have been allotted, not allotted or are pending.MOLBIO IPO GMP: WHAT DOES IT SIGNAL?The Molbio Diagnostics IPO's latest GMP stands at Rs 154, according to the latest update on August 13.With the upper price band fixed at Rs 807 per share, the current GMP indicates an estimated listing price of around Rs 961.That translates into a potential gain of around 19.08% over the issue price if the current GMP holds until listing.However, GMP is an unofficial market indicator and does not guarantee the actual listing price or returns.WHAT HAPPENS AFTER ALLOTMENT?Investors who receive shares will have them credited to their demat accounts after the allotment process is completed.For investors who do not receive an allotment, the blocked application funds will be released according to the applicable process.Molbio Diagnostics IPO had a price band of Rs 768-807 per share, with a lot size of 18 shares. At the upper price band, a retail investor needed Rs 14,526 to apply for one lot.The IPO is scheduled to list on NSE and BSE on August 17.With the issue receiving more than 70 times subscription and the latest GMP pointing to a potential premium at listing, investors will now be watching the allotment closely.(Disclaimer: The views, opinions, recommendations, and suggestions expressed by experts/brokerages in this article are their own and do not reflect the views of the India Today Group. It is advisable to consult a qualified broker or financial advisor before making any actual investment or trading choices.)- EndsPublished On: Aug 13, 2026 09:13 IST

Original Source

Read the full article at Indiatoday →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.